The integrity of tennis’s anti-doping system faces a profound crisis of confidence, with recent controversies on both ATP and WTA scenes, exposing deep-seated concerns about transparency and consistency. While the Tennis Anti-Doping Programme (TADP) administers a comprehensive testing system that collected an average of 1,905 samples annually between 2003 and 2009, resulting in a relatively low positive test rate of 0.38%, the current landscape is dominated by debates over inconsistent sanctions.

The core issue revolves around the perception that the sport operates a two-tier system, where top-ranked players receive preferential treatment compared to their lower-profile counterparts, creating what many professionals now describe as a fundamental integrity problem within the sport.

In thi

See Full Page